Details for Patent: 9,468,598
✉ Email this page to a colleague
Summary for Patent: 9,468,598
Title: | Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
Abstract: | Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder. |
Inventor(s): | Dietrich; Rango (Constance, DE), Eistetter; Klaus (Constance, DE), Ney; Hartmut (Constance, DE) |
Assignee: | AstraZeneca AB (Sodertalje, SE) |
Application Number: | 13/874,065 |
Patent Claim Types: see list of patent claims | Compound; Dosage form; Composition; |
Drugs Protected by US Patent 9,468,598
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,468,598
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 102 07 160 | Feb 20, 2002 |
02003811 | Feb 20, 2002 |
International Family Members for US Patent 9,468,598
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 038527 | ⤷ Try a Trial | |||
Austria | 550038 | ⤷ Try a Trial | |||
Australia | 2003206924 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |